written on 23.09.2021

China Biopharma Dealmaking Review H1 2021

The latest reporting on China biopharma dealmaking from MSQ Ventures, including the Top 10 biotech in-licensing deals in H1 2021, the Top 5 out-licensing deals, and Top 10 IPOs.

 

Made with Visme Infographic Maker

Made with Visme Infographic Maker

Made with Visme Infographic Maker

Similar Facts and Figures

Latest Report